[Brainlife] Newsletter, Vol.2, No.21, 5 Nov 2003

top

BRAINLIFE NEWSLETTER

Volume 2, Number 21 - 5 November 2003	Volume 2 Archive


Contents

	Diagnosis & Evaluation
	Integrative Medicine
	Prognosis & Outcome
	Psychosocial Aspects
	Treatment


Diagnosis & Evaluation

	A Bizzi, U. Danesi, B. Pollo, L. Bissola, P. Ferroli, C. Solero, A. Boiardi, G. Broggi H-MR Spectroscopic Imaging-guided Surgery of Brain Tumors and correlation with Neuropathology Proc. Int. Symp. “New Treatments for Brain Tumors: Gene Therapy and Neural Stem Cells”, Parma, Italy, October 17-20, 2001, Abstract No. O-1
	Bela Bodey, Vivian Bodey, Stuart E. Siegel, Hans E. Kaiser Mage-1, a cancer-testis antigen, and p53 expression in childhood astrocytomas as an indicator of tumor progression Proceedings of the AACR, Volume 44, 2nd ed., July 2003, Abstract No. 158
	CM Coffin, JT Braun, MR Wick and LP Dehner A clinicopathologic and immunohistochemical analysis of 53 cases of medulloblastoma with emphasis on synaptophysin expression Modern Pathology, 1990, Vol 3, Issue 2, 164-170
	VE Gould, DS Jansson, WM Molenaar, LB Rorke, JQ Trojanowski, VM Lee, RJ Packer and WW Franke Primitive neuroectodermal tumors of the central nervous system. Patterns of expression of neuroendocrine markers, and all classes of intermediate filament proteins Laboratory Investigation, 1990, Vol 62, Issue 4, 498-509
	Pearl GS, Takei Y Cerebellar "neuroblastoma": nosology as it relates to medulloblastoma Cancer. 1981 Feb 15;47(4):772-9

Integrative Medicine

	Tsutomu Arimura, Akiko Kojima-Yuasa, Mayu Suzuki, David Opare Kennedy and Isao Matsui-Yuasa Caspase-independent apoptosis induced by evening primrose extract in Ehrlich ascites tumor cells Cancer Letters, Volume 201, Issue 1, 10 November 2003, Pages 9-16
	Erdlenbruch B, Jendrossek V, Eibl H, Lakomek M Transient and controllable opening of the blood-brain barrier to cytostatic and antibiotic agents by alkylglycerols in rats Exp Brain Res 2000 Dec;135(3):417-22
	Ross DA, Kish P, Muraszko KM, Blaivas M, Strawderman M Effect of dietary vitamin A or N-acetylcysteine on ethylnitrosourea-induced rat gliomas J Neurooncol 1998 Oct;40(1):29-38
	Sung L, Greenberg ML, Koren G, Tomlinson GA, Tong A, Malkin D, Feldman BM Vitamin e: the evidence for multiple roles in cancer Nutr Cancer. 2003;46(1):1-14
	Judith A. Schwartzbaum ; David G. Cornwell Oxidant Stress and Glioblastoma Multiforme Risk: Serum Antioxidants, γ-Glutamyl Transpeptidase, and Ferritin Nutrition and Cancer, 2000, Volume: 38 Number: 1 Page: 40 -- 49

Prognosis & Outcome

	Bissola L, Eoli M, Merciai B, Silvani A, Salsano E, Broggi G, Boiardi A and Finocchiaro G Allelic losses on chromosomes 1p, 19q, 17p and 10q as predictors of survival in oligoastrocytomas Proc. Int. Symp. "New Treatments for Brain Tumors: Gene Therapy and Neural Stem Cells", Parma, Italy, October 17-20, 2001, Abstract No. P-1
	T. B. Johannesen, F. Langmark and K. Lote Cause of death and long-term survival in patients with neuro-epithelial brain tumours: a population-based study European Journal of Cancer, Volume 39, Issue 16 , November 2003, Pages 2355-2363
	Pomeroy SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, McLaughlin ME, Kim JY, Goumnerova LC, Black PM, Lau C, Allen JC, Zagzag D, Olson JM, Curran T, Wetmore C, Biegel JA, Poggio T, Mukherjee S, Rifkin R, Califano A, Stolovitzky G, Louis DN, Mesirov JP, Lander ES, Golub TR Prediction of central nervous system embryonal tumour outcome based on gene expression Nature. 2002 Jan 24;415(6870):436-42

Psychosocial Aspects

	Anne E. Kayl ; Christina A. Meyers Does brain tumor histology influence cognitive function? Neuro-Oncology, October 2003, Volume: 5, Number: 4, Page: 255 -- 260

Treatment

	Koji Adachi Synergistic Antiglioma Activity of Interleukin-12 and Interleukin-18 15th International Conference on Brain Tumor Research and Therapy. May 24–27, 2003. Sorrento, Italy. Abstract No. 1 Neuro-Oncology, Volume 5, Issue 4, October 2003
	Lissa C. Baird, Peter Canoll, and Jeffrey Bruce Effect of infiltrating tumor cells on the blood-brain barrier in a neonatal rat glioma model Society for Neuro-Oncology Eighth Annual Meeting. Keystone, Colorado. November 13–16, 2003. Abstract No. AN-01 Neuro-Oncology, Volume 5, Issue 4, October 2003
	Christian Plathow M.D., Daniela Schulz-Ertner M.D., Christoph Thilman M.D., Ivan Zuna Ph.D., Mathias Lichy M.D., Marc-André Weber M.D., Heinz-Peter Schlemmer M.D., Michael Wannenmacher M.D. and Jürgen Debus M.D., Ph.D. Fractionated stereotactic radiotherapy in low-grade astrocytomas: Long-term outcome and prognostic factors International Journal of Radiation OncologyBiologyPhysics, Volume 57, Issue 4, 15 November 2003, Pages 996-1003
	Salvatore Siena, Simona Secondino, Laura Giannetta, Ornella Carminati and Paolo Pedrazzoli Optimising management of neutropenia and anaemia in cancer chemotherapy––advances in cytokine therapy Critical Reviews in Oncology/Hematology, Vol. 48, Suppl. 1, 15 Oct. 2003, Pages S39-S47
	M. Weaver, D.W. Laske Transferrin Receptor Ligand-Targeted Toxin Conjugate (Tf-CRM107) for Therapy of Malignant Gliomas Journal of Neuro-Oncology, October 2003, Volume 65, Number 1, Pages 3 -- 14
	Paul M. Zeltzer, James M. Boyett, Jonathan L. Finlay, A. Lel Albright, Lucy B. Rorke, Jerrold M. Milstein, Jeffrey C. Allen, Kenneth R. Stevens, Philip Stanley, Hao Li, Jeffrey H. Wisoff, J. Russell Geyer, Patsy McGuire-Cullen, James A. Stehbens, Susan B. Shurin, Roger J. Packer Metastasis Stage, Adjuvant Treatment, and Residual Tumor Are Prognostic Factors for Medulloblastoma in Children: Conclusions From the Children's Cancer Group 921 Randomized Phase III Study Journal of Clinical Oncology, Vol 17, Issue 3 (March), 1999: 832

bottom